217 related articles for article (PubMed ID: 29303829)
61. Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.
Carlsson AC; Wändell P; Sundquist K; Johansson SE; Sundquist J
Hypertens Res; 2014 Jun; 37(6):553-9. PubMed ID: 24599014
[TBL] [Abstract][Full Text] [Related]
62. A rational approach to hypertension treatment in the older patient.
Flack JM; Woolley A; Esunge P; Grimm RH
Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
[No Abstract] [Full Text] [Related]
63. Have ALLHAT, ANBP2, ASCOT-BPLA, and so forth improved our knowledge about better hypertension care?
Sawicki PT; McGauran N
Hypertension; 2006 Jul; 48(1):1-7. PubMed ID: 16735646
[No Abstract] [Full Text] [Related]
64. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
65. Management of hypertension in patients with CKD: differences between primary and tertiary care settings.
Minutolo R; De Nicola L; Zamboli P; Chiodini P; Signoriello G; Toderico C; Arfè G; Boschi G; Brancati C; Iaccarino P; Conte G
Am J Kidney Dis; 2005 Jul; 46(1):18-25. PubMed ID: 15983953
[TBL] [Abstract][Full Text] [Related]
66. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
67. [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
Gurevich MA
Klin Med (Mosk); 2002; 80(9):9-13. PubMed ID: 12416217
[No Abstract] [Full Text] [Related]
68. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
69. First-line drugs for hypertension.
Wright JM; Musini VM
Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
[TBL] [Abstract][Full Text] [Related]
70. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
71. [Are the newer antihypertensive agents better and more effective than diuretics?].
Landmark K
Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
[TBL] [Abstract][Full Text] [Related]
72. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
73. [Old or new antihypertensives--which are better?].
Schrader J; Kulschewski A
MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
[TBL] [Abstract][Full Text] [Related]
74. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
75. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.
Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH
JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112
[TBL] [Abstract][Full Text] [Related]
76. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
77. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
78. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
79. Current drug treatment and treatment patterns with antihypertensive drugs.
Freis ED; Papademetriou V
Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
[TBL] [Abstract][Full Text] [Related]
80. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
Zanchetti A
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
